Search Results - "LEKUONA, Iñaki"

Adverse Clinical Outcomes and Associated Predictors in Rivaroxaban-Treated Atrial Fibrillation Patients With Renal Impairment by Rivera-Caravaca, José Miguel, Anguita Sanchez, Manuel, Sanmartín Fernández, Marcelo, Rafols, Carles, Barón-Esquivias, Gonzalo, Arribas Ynsaurriaga, Fernando, Freixa-Pamias, Román, Lekuona Goya, Iñaki, Vázquez Rodríguez, José Manuel, Pérez-Cabeza, Alejandro I., Cosín-Sales, Juan, Ureña Montilla, Isabel, Álvarez-Vieitez Blanco, Antonio, Marín, Francisco

“…Renal impairment confers worse prognosis in patients with atrial fibrillation (AF) but there is scarce evidence about the influence of direct-acting oral…”
Get full text

Benefit of primary percutaneous coronary interventions in the elderly with ST segment elevation myocardial infarction by Fernández-Bergés, Daniel, Degano, Irene R, Gonzalez Fernandez, Reyes, Subirana, Isaac, Vila, Joan, Jiménez-Navarro, Manuel, Perez-Fernandez, Silvia, Roqué, Mercé, Bayes-Genis, Antoni, Fernandez-Aviles, Francisco, Mayorga, Antonio, Bertomeu-Gonzalez, Vicente, Sanchis, Juan, Rodríguez Esteban, Marcos, Sanchez-Hidalgo, Antonio, Sanchez-Insa, Esther, Elorriaga, Ane, Abu Assi, Emad, Nuñez, Alberto, Garcia Ruiz, Jose Manuel, Morrondo Valdeolmillos, Pedro, Bosch-Portell, Daniel, Lekuona, Iñaki, Carrillo-Lopez, Andres, Zamora, Alberto, Vega-Hernandez, Berta, Alameda Serrano, Javier, Rubert, Catalina, Ruiz-Valdepeñas, Luis, Quintas, Laura, Rodríguez-Padial, Luis, Vaquero, Jessica, Martinez Dolz, Luis, Barrabes, Jose A, Sanchez, Pedro L, Sionis, Alessandro, Martí-Almor, Julio, Elosua, Roberto, Lidon, Rosa-María, Garcia-Dorado, David, Marrugat, Jaume

“…Primary percutaneous coronary intervention (P-PCI) has demonstrated its efficacy in patients with ST segment elevation myocardial infarction (STEMI). However,…”
Get full text

The effect of post-discharge educational intervention on patients in achieving objectives in modifiable risk factors six months after discharge following an episode of acute coronary syndrome, (CAM-2 Project): a randomized controlled trial by Muñiz, Javier, Gómez-Doblas, Juan J, Santiago-Pérez, María I, Lekuona-Goya, Iñaki, Murga-Eizagaetxebarría, Nekane, de Teresa-Galván SS, Eduardo, Cruz-Fernández, José M, Castro-Beiras, Alfonso

“…We investigated whether an intervention mainly consisting of a signed agreement between patient and physician on the objectives to be reached, improves…”
Get full text

Quince años de intervencionismo percutáneo de la oclusión total coronaria crónica.: Experiencia, resultados y pronóstico clínico by Cacicedo Fernández de Bobadilla, Ángela, Sadaba, Mario, Subinas, Asier, Oria, Garazi, Zugazabeitia, G, Rumoroso Cuevas, José R, Torre Hernández, José M. de la, Romero Borque, A, Quintana, Olga, Urkullu, Alazne, Lekuona, Iñaki, Onaindia Gandarias, José Juan

“…Introduction and objectives: Chronic total coronary occlusion (CTO) is often a complex entity to deal with through a percutaneous coronary intervention, and…”
Get full text

Outcomes and factors associated with mortality in patients with atrial fibrillation and heart failure: FARAONIC study by Gómez Doblas, Juan José, Cepeda‐Rodrigo, José María, Agra Bermejo, Rosa, Blanco Labrador, Elvira, Blasco, Maria Teresa, Carrera Izquierdo, Margarita, Lekuona, Iñaki, Recio Mayoral, Alejandro, Rafols, Carles, Manito, Nicolás

“…Abstract Background Heart failure (HF) and atrial fibrillation (AF) are common and coexistent conditions. Hypothesis To investigate the adverse events and…”
Get full text

Use of rivaroxaban attenuates renal function impairment in patients with atrial fibrillation: insights of the EMIR study by López‐Gálvez, Raquel, Rivera‐Caravaca, José Miguel, Anguita Sánchez, Manuel, Sanmartín Fernández, Marcelo, Rafols, Carles, Pérez‐Cabeza, Alejandro Isidoro, Barón Esquivias, Gonzalo, Lekuona Goya, Iñaki, Vázquez Rodríguez, José Manuel, Cosín Sales, Juan, Arribas Ynsaurriaga, Fernando, Barrios, Vivencio, Freixa‐Pamias, Román, Marín, Francisco

“…Background In atrial fibrillation (AF) patients on vitamin K antagonists, a progressive deterioration of renal function is common but there is limited evidence…”
Get full text

Variables affecting the quality of anticoagulation in atrial fibrillation patients newly initiating vitamin K antagonists: insights from the national and multicentre SULTAN registry by Rivera-Caravaca, José Miguel, Badimón, Lina, Ferreira-Gonzalez, Ignacio, Gómez-Doblas, Juan José, Roca-Luque, Ivo, Lekuona, Iñaki, Jiménez-Candil, Javier, Rodríguez-Padial, Luis, González-Juanatey, Carlos, Calvo-Jambrina, Román, Fácila, Lorenzo, Ruiz-Ortiz, Martín, Anguita, Manuel, Marín, Francisco

“…Abstract Aims Vitamin K antagonists (VKAs) are effective drugs reducing the risk for stroke in atrial fibrillation (AF), but the benefits derived from such…”
Get full text

Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxaban by Marín, Francisco, Fernández, Marcelo Sanmartín, Barón-Esquivias, Gonzalo, Barrios, Vivencio, Lekuona, Iñaki, Pérez-Cabeza, Alejandro I, Masjuan, Jaime, Del Vigo, Esther Recalde, Vázquez Rodríguez, José Manuel, Freixa-Pamias, Roman, Schilling, Vanessa Roldán, Arribas, Fernando, Priu, Carles Rafols, Sánchez, Manuel Anguita

“…It is not well known how comorbidities may change the prognosis of atrial fibrillation (AF) patients. This study was aimed to analyze the impact of…”
Get full text

Outcomes and predictive value of the 2MACE score in patients with atrial fibrillation treated with rivaroxaban in a prospective, multicenter observational study: The EMIR study by Sanmartín Fernández, Marcelo, Anguita Sánchez, Manuel, Arribas, Fernando, Barón-Esquivias, Gonzalo, Barrios, Vivencio, Cosin-Sales, Juan, Esteve-Pastor, María Asunción, Freixa-Pamias, Roman, Lekuona, Iñaki, Pérez-Cabeza, Alejandro I, Ureña, Isabel, Vázquez Rodríguez, José Manuel, Rafols Priu, Carles, Marin, Francisco

“…The aim of the study was to evaluate the performance of the 2MACE in patients with atrial fibrillation (AF) treated with rivaroxaban and to improve the…”
Get full text

Impact of heart failure on the clinical profile and outcomes in patients with atrial fibrillation treated with rivaroxaban. Data from the EMIR study by Anguita Sánchez, Manuel, Marín, Francisco, Masjuan, Jaime, Cosín-Sales, Juan, Vázquez Rodríguez, José Manuel, Barrios, Vivencio, Barón-Esquivias, Gonzalo, Lekuona, Iñaki, Pérez-Cabeza, Alejandro I, Freixa-Pamias, Román, Parra Jimenez, Francisco Javier, Monzer Khanji Khatib, Mohamed, Rafols Priu, Carles, Sanmartín Fernández, Marcelo

“…The aim of this study was to analyze the impact of the presence of heart failure (HF) on the clinical profile and outcomes in patients with atrial fibrillation…”
Get full text

Rivaroxaban for the prevention of outcomes in patients with atrial fibrillation in clinical practice: an indirect comparison of national and international registries by Marin, Francisco, Fernández, Marcelo Sanmartín, Lekuona, Iñaki, Arribas, Fernando, Barón-Esquivias, Gonzalo, Barrios, Vivencio, Cosin-Sales, Juan, Freixa-Pamias, Román, Masjuan, Jaime, Pérez-Cabeza, Alejandro I, Schilling, Vanessa Roldán, Vázquez Rodríguez, José Manuel, Priu, Carles Rafols, Sánchez, Manuel Anguita

“…To analyze the effectiveness and safety of rivaroxaban in patients with atrial fibrillation (AF). The clinical profile and outcomes of the EMIR study were…”
Get full text

Would the Use of Edoxaban Be Cost-effective for the Prevention of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation in Spain? by Lekuona, Iñaki, Anguita, Manuel, Zamorano, José Luis, Rodríguez, José Manuel, Barja de Soroa, Paloma, Pérez-Alcántara, Ferran

“…Abstract Introduction and objectives To assess the cost-effectiveness of edoxaban vs acenocoumarol in the prevention of stroke and systemic embolism in…”
Get full text

Gender differences in drug titration among heart failure patients with reduced ejection fraction in the ETIFIC trial by Oyanguren, Juana, Díaz-Molina, Beatriz, Lekuona, Iñaki, González-Costello, José, López-Fernández, Silvia, García-Pinilla, José M., Garcia-Garrido, Lluisa, López-Moyano, Gracia, Manito, Nicolás, Cobo-Marcos, Marta, Nebot-Margalef, Magdalena, Latorre-García, Pedro, Arana-Arri, Eunate, Pérez-Fernández, Silvia, Torcal-Laguna, Jesús

“…INTRODUCTION AND OBJECTIVESOptimal medical therapy decreases mortality and heart failure (HF) hospitalizations in HF patients with reduced left ventricular…”
Get full text

Fifteen years of percutaneous coronary interventions for chronic total coronary occlusions. Experience, results, and clinical outcomes by R. Rumoroso, José, Subinas, Asier, Sádaba, Mario, J. Onaindia, José, Oria, Garazi, Zugazabeitia, Germán, Romero, Alaitz, Cacicedo, Ángela, Urkullu, Alazne, Quintana, Olga, Lekuona, Iñaki, Torre Hernández, José M. de la

“…ABSTRACT Introduction and objectives: Chronic total coronary occlusion (CTO) is often a complex entity to deal with through a percutaneous coronary…”
Get full text

Congestive heart failure in a hypertensive patient (don't forget the stethoscope) by Lekuona, IñTaki, Laraudogoitia, Eva, Salcedo, Alberto, Sádaba, Mario

“…A 56-year-old woman was admitted in October, 1999, with worsening dyspnoea and palpitations of 3 months duration. She had orthopnoea, paroxysmal nocturnal…”
Get full text

PCSK9 Inhibitors: From Innovation to Sustainable Clinical Application by Lekuona, Iñaki

Get full text

Los inhibidores de PCSK9, de la innovación a la aplicación clínica sostenible by Lekuona, Iñaki

Get full text

Drug titration by nursing professionals in heart failure units. Response by Oyanguren, Juana, Garcia-Garrido, Lluisa, González-Costello, José, Lekuona, Iñaki

Get full text

Cardiologists and the Cardiology of the Future. Vision and proposals of the Spanish Society of Cardiology for the Cardiology of the 21st Century by Sánchez, Manuel Anguita, Martín, Joaquín J. Alonso, Fillat, Ángel Cequier, Doblas, Juan José Gómez, Rivera, Luis Pulpón, Goya, Iñaki Lekuona, Rodrigo, Francisco Rodríguez, Romo, Andrés Íñiguez, Miguel, Carlos Macaya, Masip, Arturo Evangelista, Melchor, Lorenzo Silva, Bueno, Héctor, Molina, Beatriz Díaz, Ferreira-González, Ignacio, Elola Somoza, Francisco Javier

“…AbstractThe Cardiology of the Future is a project of the Spanish Society of Cardiology (SEC) whose objectives are as follows: to define the action policies of…”
Get full text

Clinical profile and outcomes in very elderly patients with atrial fibrillation anticoagulated with rivaroxaban: data from the EMIR study by Marín, Francisco, Sánchez, Manuel Anguita, Lekuona, Iñaki, Fernández, Marcelo Sanmartín, Barrios, Vivencio, Muñoz, Carlos Perez, Cosín-Sales, Juan, Pérez Cabeza, Alejandro I, Schilling, Vanesa Roldán, Priu, Carles Rafols, Orenes-Piñero, Esteban, Esteve-Pastor, María Asunción

“…To analyze the clinical profile, adequacy of treatment with rivaroxaban and outcomes in octogenarians with atrial fibrillation (AF), taking rivaroxaban in…”
Get full text